Regenxbio Inc (RGNX)

Stock-Based Compensation

$9.05M

Quarterly · Period ending: · USD

RGNX logo

RGNX Stock-Based Compensation

Latest reported$9.05M
RGNX Quarterly Stock-Based Comp ($0.00 → $9.05M)
High-resolution chart · PNG

RGNX stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
9,053,000
8,617,000
8,375,000
8,998,000
8,653,000
8,537,000
9,542,000
9,884,000
9,435,000
9,602,000
8,338,000
10,219,000
10,504,000
11,206,000
9,408,000
10,245,000
10,335,000
10,800,000
9,162,000
9,734,000
0
9,920,000
7,581,000
8,035,000
8,316,000
8,017,000
6,875,000
7,162,000
7,099,000
5,718,000
4,886,000
4,483,000
3,981,000
3,291,000
2,796,000
2,735,000
2,483,000
2,591,000
2,000,000
1,829,000
1,656,000
1,546,000
862,000
1,348,000
635,000
76,000
99,000
220,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.